Breaking News Instant updates and real-time market news.

BAYRY

Bayer

$0.00 /

+ (+0.00%)

12:24
09/15/20
09/15
12:24
09/15/20
12:24

Bayer resolves thousands of U.S. Roundup cases with trial lawyers, Reuters says

Bayer has resolved thousands of U.S. Roundup weed killer suits as part of a $11B settlement, reaching agreements with the only lawyers who took cases to trial over claims that the product caused cancer, Reuters' Tom Hals reports. In letters filed with the U.S. District Court in San Francisco, three lawyers said that had agreed to binding settlements of their lawsuits, Hals says. The settlements covered 15,000 suits, the author says, citing an attorney familiar with the talks. Reference Link

BAYRY Bayer
$0.00 /

+ (+0.00%)

09/14/20 Morgan Stanley
Bayer price target lowered to EUR 82 from EUR 83 at Morgan Stanley
09/10/20
Fly Intel: Top five analyst initiations
09/10/20 Roth Capital
Dare Bioscience resumed with a Buy at Roth Capital
09/09/20 BMO Capital
Bayer initiated with a Market Perform at BMO Capital

TODAY'S FREE FLY STORIES

Upgrade
Corporate Office upgraded at Raymond James, pullback creates good entry point » 08:10
10/27/20
10/27
08:10
10/27/20
08:10
OFC

Corporate Office Properties

$23.52 /

-0.9 (-3.69%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OFC Corporate Office Properties
$23.52 /

-0.9 (-3.69%)

06:07 Today Raymond James
Corporate Office Properties upgraded to Outperform from Market Perform at Raymond James
08/25/20 JPMorgan
Corporate Office Properties price target raised to $31 from $29 at JPMorgan
08/13/20
Fly Intel: Top five analyst downgrades
08/13/20 Baird
Baird downgrades Corporate Office Properties after recent outperformance
OFC Corporate Office Properties
$23.52 /

-0.9 (-3.69%)

Conference/Events
Kala Pharmaceuticals to host conference call » 08:10
10/27/20
10/27
08:10
10/27/20
08:10
KALA

Kala Pharmaceuticals

$7.70 /

-0.05 (-0.65%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KALA Kala Pharmaceuticals
$7.70 /

-0.05 (-0.65%)

KALA Kala Pharmaceuticals
$7.70 /

-0.05 (-0.65%)

09/14/20
Fly Intel: Top five analyst downgrades
09/14/20 Jefferies
Jefferies downgrades Kala to Hold, cuts target to $10 following physician survey
09/14/20 Jefferies
Kala Pharmaceuticals downgraded to Hold from Buy at Jefferies
08/28/20 Wedbush
Kala Pharmaceuticals removed from Best Ideas List at Wedbush
KALA Kala Pharmaceuticals
$7.70 /

-0.05 (-0.65%)

  • 11
    Mar
KALA Kala Pharmaceuticals
$7.70 /

-0.05 (-0.65%)

Hot Stocks
Brookfield closes EUR1.14B European core-plus real estate fund » 08:10
10/27/20
10/27
08:10
10/27/20
08:10
BAM

Brookfield

$32.60 /

-1.31 (-3.86%)

Brookfield Asset…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BAM Brookfield
$32.60 /

-1.31 (-3.86%)

BAM Brookfield
$32.60 /

-1.31 (-3.86%)

10/23/20 Credit Suisse
Athene could still bid for American Equity, faces 'hurdles,' says Credit Suisse
10/19/20
Fly Intel: Top five analyst upgrades
10/19/20 Citi
Brookfield upgraded to Buy from Neutral at Citi
09/23/20 JPMorgan
Brookfield shares remain undervalued, says JPMorgan
BAM Brookfield
$32.60 /

-1.31 (-3.86%)

BAM Brookfield
$32.60 /

-1.31 (-3.86%)

BAM Brookfield
$32.60 /

-1.31 (-3.86%)

Initiation
Academy Sports initiated with an Overweight at JPMorgan » 08:09
10/27/20
10/27
08:09
10/27/20
08:09
ASO

Academy Sports

$14.80 /

+0.28 (+1.93%)

JPMorgan analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASO Academy Sports
$14.80 /

+0.28 (+1.93%)

06:41 Today Stephens
Academy Sports initiated with an Overweight at Stephens
06:33 Today BofA
Academy Sports initiated with a Buy at BofA
06:15 Today Guggenheim
Academy Sports initiated with a Buy at Guggenheim
06:02 Today BofA
Academy Sports initiated with a Buy at BofA
  • 02
    Oct
ASO Academy Sports
$14.80 /

+0.28 (+1.93%)

Earnings
Xerox reports Q3 adjusted EPS 48c, consensus 24c » 08:09
10/27/20
10/27
08:09
10/27/20
08:09
XRX

Xerox

$18.92 /

-0.81 (-4.11%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XRX Xerox
$18.92 /

-0.81 (-4.11%)

XRX Xerox
$18.92 /

-0.81 (-4.11%)

10/13/20 Morgan Stanley
Morgan Stanley upgrades IT Hardware industry view to Attractive from In-Line
07/24/20
Fly Intel: Top five analyst downgrades
07/24/20 JPMorgan
JPMorgan downgrades Xerox to Underweight, sees long recovery
07/24/20 JPMorgan
Xerox downgraded to Underweight from Neutral at JPMorgan
XRX Xerox
$18.92 /

-0.81 (-4.11%)

XRX Xerox
$18.92 /

-0.81 (-4.11%)

XRX Xerox
$18.92 /

-0.81 (-4.11%)

Hot Stocks
Infinera, ESnet partner to upgrade scientific data network » 08:08
10/27/20
10/27
08:08
10/27/20
08:08
INFN

Infinera

$6.70 /

+0.02 (+0.30%)

Infinera announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INFN Infinera
$6.70 /

+0.02 (+0.30%)

INFN Infinera
$6.70 /

+0.02 (+0.30%)

09/04/20 B. Riley FBR
Infinera, Extreme, Viavi selloffs yesterday overdone, says B. Riley FBR
09/04/20 Morgan Stanley
Ciena price target lowered to $46 from $50 at Morgan Stanley
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Stifel
Infinera upgraded to Buy from Hold at Stifel
INFN Infinera
$6.70 /

+0.02 (+0.30%)

INFN Infinera
$6.70 /

+0.02 (+0.30%)

INFN Infinera
$6.70 /

+0.02 (+0.30%)

Upgrade
AnaptysBio upgraded to Outperform at Wedbush » 08:07
10/27/20
10/27
08:07
10/27/20
08:07
ANAB

AnaptysBio

$27.65 /

+1.88 (+7.30%)

, GSK

GlaxoSmithKline

$35.21 /

-0.09 (-0.25%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANAB AnaptysBio
$27.65 /

+1.88 (+7.30%)

GSK GlaxoSmithKline
$35.21 /

-0.09 (-0.25%)

ANAB AnaptysBio
$27.65 /

+1.88 (+7.30%)

06:58 Today Wedbush
AnaptysBio upgraded to Outperform from Neutral at Wedbush
10/14/20 Truist
AnaptysBio price target raised to $20 from $16 at Truist
10/14/20 Guggenheim
AnaptysBio upgraded to Buy from Neutral at Guggenheim
01/16/20 Cantor Fitzgerald
AnaptysBio risk/reward favorable into second half data, says Cantor Fitzgerald
GSK GlaxoSmithKline
$35.21 /

-0.09 (-0.25%)

10/15/20 SVB Leerink
SVB Leerink sees possible opportunity for Amarin to 'salvage Vascepa' in U.S.
10/12/20 UBS
GlaxoSmithKline price target lowered to 1,730 GBp from 1,800 GBp at UBS
10/09/20 Morgan Stanley
GlaxoSmithKline price target lowered to 1,695 GBp from 1,700 GBp at Morgan Stanley
10/08/20 JPMorgan
JPMorgan backs Neutral on GSK ahead of Q3 results
ANAB AnaptysBio
$27.65 /

+1.88 (+7.30%)

GSK GlaxoSmithKline
$35.21 /

-0.09 (-0.25%)

GSK GlaxoSmithKline
$35.21 /

-0.09 (-0.25%)

ANAB AnaptysBio
$27.65 /

+1.88 (+7.30%)

GSK GlaxoSmithKline
$35.21 /

-0.09 (-0.25%)

GSK GlaxoSmithKline
$35.21 /

-0.09 (-0.25%)

Initiation
Oncorus initiated with a Buy at Jefferies » 08:07
10/27/20
10/27
08:07
10/27/20
08:07
ONCR

Oncorus

$16.06 /

+0.51 (+3.28%)

, REPL

Replimune Group

$42.68 /

-2.59 (-5.72%)

Jefferies analyst Maury…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ONCR Oncorus
$16.06 /

+0.51 (+3.28%)

REPL Replimune Group
$42.68 /

-2.59 (-5.72%)

ONCR Oncorus
$16.06 /

+0.51 (+3.28%)

07:39 Today Evercore ISI
Oncorus initiated with an Outperform at Evercore ISI
04:43 Today Piper Sandler
Oncorus initiated with an Overweight at Piper Sandler
REPL Replimune Group
$42.68 /

-2.59 (-5.72%)

10/15/20 BMO Capital
Replimune Group price target raised to $51 from $40 at BMO Capital
10/15/20 Barclays
Replimune Group price target raised to $50 from $29 at Barclays
10/15/20 H.C. Wainwright
Replimune Group upgraded to Buy from Neutral at H.C. Wainwright
10/14/20 Roth Capital
Replimune Group price target raised to $50 from $30 at Roth Capital
REPL Replimune Group
$42.68 /

-2.59 (-5.72%)

  • 22
    Oct
  • 02
    Oct
  • 09
    Jun
  • 14
    Nov
ONCR Oncorus
$16.06 /

+0.51 (+3.28%)

REPL Replimune Group
$42.68 /

-2.59 (-5.72%)

Hot Stocks
VMware announces alliance with Samsung to extend 5G competency » 08:07
10/27/20
10/27
08:07
10/27/20
08:07
VMW

VMware

$142.67 /

-6.51 (-4.36%)

, SSNLF

Samsung

$0.00 /

+ (+0.00%)

VMware, Inc. (VMW)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VMW VMware
$142.67 /

-6.51 (-4.36%)

SSNLF Samsung
$0.00 /

+ (+0.00%)

VMW VMware
$142.67 /

-6.51 (-4.36%)

10/23/20 Morgan Stanley
Citrix downgraded to Equal Weight on slower cloud progress at Morgan Stanley
10/20/20 KeyBanc
VMware price target raised to $180 from $170 at KeyBanc
10/15/20 JPMorgan
Dell Technologies price target raised to $80 from $70 at JPMorgan
10/13/20 UBS
VMware initiated with a Neutral at UBS
SSNLF Samsung
$0.00 /

+ (+0.00%)

10/01/20 KeyBanc
No major surprises around Google's device launches, says KeyBanc
09/21/20 Susquehanna
Samsung upgraded to Positive from Neutral at Susquehanna
09/09/20 Loop Capital
Qorvo price target raised to $155 from $147 at Loop Capital
09/08/20 Raymond James
Nokia downgraded to Market Perform from Strong Buy at Raymond James
VMW VMware
$142.67 /

-6.51 (-4.36%)

SSNLF Samsung
$0.00 /

+ (+0.00%)

VMW VMware
$142.67 /

-6.51 (-4.36%)

SSNLF Samsung
$0.00 /

+ (+0.00%)

VMW VMware
$142.67 /

-6.51 (-4.36%)

SSNLF Samsung
$0.00 /

+ (+0.00%)

VMW VMware
$142.67 /

-6.51 (-4.36%)

Earnings
Franklin Electric raises FY20 EPS ex-restructuring view to $2.10-$2.15 » 08:07
10/27/20
10/27
08:07
10/27/20
08:07
FELE

Franklin Electric

$62.53 /

-0.58 (-0.92%)

Previous view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FELE Franklin Electric
$62.53 /

-0.58 (-0.92%)

FELE Franklin Electric
$62.53 /

-0.58 (-0.92%)

09/29/20 Baird
Franklin Electric upgraded to Outperform at Baird
09/29/20 Baird
Franklin Electric upgraded to Outperform from Neutral at Baird
07/02/20
Fly Intel: Top five analyst downgrades
07/02/20 DA Davidson
Franklin Electric downgraded to Neutral from Buy at DA Davidson
FELE Franklin Electric
$62.53 /

-0.58 (-0.92%)

Hot Stocks
3M sees October revenue flat to up low-single digits year-on-year » 08:07
10/27/20
10/27
08:07
10/27/20
08:07
MMM

3M

$166.24 /

-3.565 (-2.10%)

The company estimates…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MMM 3M
$166.24 /

-3.565 (-2.10%)

MMM 3M
$166.24 /

-3.565 (-2.10%)

10/07/20
Fly Intel: Top five analyst upgrades
10/07/20 JPMorgan
3M price target raised to $170 from $159 at JPMorgan
10/07/20 Gordon Haskett
Gordon Haskett upgrades 3M to Hold ahead of potential 'catch-up' trade
10/07/20 Gordon Haskett
3M upgraded to Hold from Underperform at Gordon Haskett
MMM 3M
$166.24 /

-3.565 (-2.10%)

MMM 3M
$166.24 /

-3.565 (-2.10%)

MMM 3M
$166.24 /

-3.565 (-2.10%)

MMM 3M
$166.24 /

-3.565 (-2.10%)

Hot Stocks
CytRx highlights Orphazyme announcement to accelerate arimoclomol activities » 08:06
10/27/20
10/27
08:06
10/27/20
08:06
CYTR

CytRx

$0.30 /

+ (+0.00%)

, ORPH

Orphazyme

$10.69 /

+0.69 (+6.90%)

CytRx (CYTR) highlighted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CYTR CytRx
$0.30 /

+ (+0.00%)

CYTR CytRx
$0.30 /

+ (+0.00%)

ORPH Orphazyme
$10.69 /

+0.69 (+6.90%)

10/26/20 Guggenheim
Orphazyme initiated with a Buy at Guggenheim
10/26/20 BofA
Orphazyme initiated with a Buy at BofA
10/26/20 BofA
Orphazyme initiated with a Buy at BofA
  • 29
    Sep
ORPH Orphazyme
$10.69 /

+0.69 (+6.90%)

Conference/Events
Apellis to host conference call » 08:06
10/27/20
10/27
08:06
10/27/20
08:06
APLS

Apellis

$35.92 /

+0.11 (+0.31%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APLS Apellis
$35.92 /

+0.11 (+0.31%)

APLS Apellis
$35.92 /

+0.11 (+0.31%)

09/01/20
Fly Intel: Top five analyst initiations
08/31/20 Stifel
Apellis initiated with a Buy at Stifel
07/20/20 Roth Capital
Apellis initiated with a Buy at Roth Capital
06/16/20 BTIG
Apellis initiated with a Neutral at BTIG
APLS Apellis
$35.92 /

+0.11 (+0.31%)

  • 09
    Jan
Initiation
Kubient initiated with a Buy at Maxim » 08:06
10/27/20
10/27
08:06
10/27/20
08:06
KBNT

Kubient

$3.11 /

-0.28 (-8.26%)

Maxim analyst Jack Vander…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KBNT Kubient
$3.11 /

-0.28 (-8.26%)

KBNT Kubient
$3.11 /

-0.28 (-8.26%)

Recommendations
WesBanco price target raised to $22 from $20 at B. Riley Securities » 08:05
10/27/20
10/27
08:05
10/27/20
08:05
WSBC

WesBanco

$25.05 /

+0.16 (+0.64%)

B. Riley Securities…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WSBC WesBanco
$25.05 /

+0.16 (+0.64%)

WSBC WesBanco
$25.05 /

+0.16 (+0.64%)

10/26/20 Piper Sandler
WesBanco price target raised to $29 from $26 at Piper Sandler
09/24/20 Boenning & Scattergood
WesBanco resumed with an Outperform at Boenning & Scattergood
07/09/20 Piper Sandler
WesBanco resumed with an Overweight at Piper Sandler
06/17/20 Raymond James
WesBanco upgraded to Outperform from Market Perform at Raymond James
WSBC WesBanco
$25.05 /

+0.16 (+0.64%)

Earnings
Franklin Electric reports Q3 EPS 82c, consensus 64c » 08:05
10/27/20
10/27
08:05
10/27/20
08:05
FELE

Franklin Electric

$62.53 /

-0.58 (-0.92%)

Reports Q3 revenue $351M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FELE Franklin Electric
$62.53 /

-0.58 (-0.92%)

FELE Franklin Electric
$62.53 /

-0.58 (-0.92%)

09/29/20 Baird
Franklin Electric upgraded to Outperform at Baird
09/29/20 Baird
Franklin Electric upgraded to Outperform from Neutral at Baird
07/02/20
Fly Intel: Top five analyst downgrades
07/02/20 DA Davidson
Franklin Electric downgraded to Neutral from Buy at DA Davidson
FELE Franklin Electric
$62.53 /

-0.58 (-0.92%)

Hot Stocks
AMC says several Northern California locations including San Francisco to reopen » 08:05
10/27/20
10/27
08:05
10/27/20
08:05
AMC

AMC Entertainment

$2.76 /

-0.22 (-7.39%)

AMC Entertainment…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMC AMC Entertainment
$2.76 /

-0.22 (-7.39%)

AMC AMC Entertainment
$2.76 /

-0.22 (-7.39%)

10/26/20 Citi
AMC Entertainment price target lowered to $3 from $4 at Citi
10/12/20 B. Riley Securities
AMC Entertainment price target lowered to $4.50 from $5.50 at B. Riley Securities
10/12/20 William Blair
William Blair suspends AMC Entertainment coverage due to uncertainty
09/14/20 B. Riley FBR
AMC Entertainment price target raised to $5.50 from $4 at B. Riley FBR
AMC AMC Entertainment
$2.76 /

-0.22 (-7.39%)

AMC AMC Entertainment
$2.76 /

-0.22 (-7.39%)

AMC AMC Entertainment
$2.76 /

-0.22 (-7.39%)

AMC AMC Entertainment
$2.76 /

-0.22 (-7.39%)

Recommendations
Roth Capital sees a Las Vegas divesture as positive for Las Vegas Sands shares » 08:03
10/27/20
10/27
08:03
10/27/20
08:03
LVS

Las Vegas Sands

$49.14 /

-1.55 (-3.06%)

, WYNN

Wynn Resorts

$73.42 /

-3.13 (-4.09%)

, MGM

MGM Resorts

$22.13 /

-1.24 (-5.31%)

Commenting on reports…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LVS Las Vegas Sands
$49.14 /

-1.55 (-3.06%)

WYNN Wynn Resorts
$73.42 /

-3.13 (-4.09%)

MGM MGM Resorts
$22.13 /

-1.24 (-5.31%)

LVS Las Vegas Sands
$49.14 /

-1.55 (-3.06%)

10/22/20 JPMorgan
Las Vegas Sands price target raised to $58 from $50 at JPMorgan
10/22/20 Stifel
Las Vegas Sands price target lowered to $60 from $64 at Stifel
10/20/20 JPMorgan
Las Vegas Sands price target lowered to $50 from $57 at JPMorgan
10/20/20 Deutsche Bank
Las Vegas Sands price target lowered to $58 from $60 at Deutsche Bank
WYNN Wynn Resorts
$73.42 /

-3.13 (-4.09%)

10/22/20 Deutsche Bank
Wynn Resorts price target lowered to $93 from $97 at Deutsche Bank
10/19/20
Fly Intel: Top five analyst downgrades
10/19/20 Union Gaming
Wynn Resorts downgraded to Hold on 'elusive' Macau recovery at Union Gaming
10/19/20 Union Gaming
Wynn Resorts downgraded to Hold from Buy at Union Gaming
MGM MGM Resorts
$22.13 /

-1.24 (-5.31%)

10/12/20
Fly Intel: Top five analyst downgrades
10/12/20 Barclays
MGM Resorts downgraded to Underweight from Equal Weight at Barclays
10/05/20 Roth Capital
Macau numbers likely to go lower again, says Roth Capital
09/24/20 Truist
Truist raises price targets on select Gaming names
LVS Las Vegas Sands
$49.14 /

-1.55 (-3.06%)

WYNN Wynn Resorts
$73.42 /

-3.13 (-4.09%)

MGM MGM Resorts
$22.13 /

-1.24 (-5.31%)

LVS Las Vegas Sands
$49.14 /

-1.55 (-3.06%)

WYNN Wynn Resorts
$73.42 /

-3.13 (-4.09%)

MGM MGM Resorts
$22.13 /

-1.24 (-5.31%)

LVS Las Vegas Sands
$49.14 /

-1.55 (-3.06%)

WYNN Wynn Resorts
$73.42 /

-3.13 (-4.09%)

MGM MGM Resorts
$22.13 /

-1.24 (-5.31%)

LVS Las Vegas Sands
$49.14 /

-1.55 (-3.06%)

WYNN Wynn Resorts
$73.42 /

-3.13 (-4.09%)

MGM MGM Resorts
$22.13 /

-1.24 (-5.31%)

Hot Stocks
CVS Pharmacy launches QuickRenew contact lens prescription renewal tool » 08:03
10/27/20
10/27
08:03
10/27/20
08:03
CVS

CVS Health

$59.57 /

-0.66 (-1.10%)

CVS Pharmacy, the retail…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CVS CVS Health
$59.57 /

-0.66 (-1.10%)

CVS CVS Health
$59.57 /

-0.66 (-1.10%)

09/21/20 Citi
Citi sees ACA remaining law despite Ginsburg death
09/17/20
Fly Intel: Top five analyst initiations
09/17/20 Piper Sandler
CVS Health initiated with an Overweight at Piper Sandler
08/06/20 Deutsche Bank
CVS Health price target lowered to $104 from $109 at Deutsche Bank
CVS CVS Health
$59.57 /

-0.66 (-1.10%)

CVS CVS Health
$59.57 /

-0.66 (-1.10%)

CVS CVS Health
$59.57 /

-0.66 (-1.10%)

CVS CVS Health
$59.57 /

-0.66 (-1.10%)

Hot Stocks
RMR Group executes five-year lease extension in Austin » 08:03
10/27/20
10/27
08:03
10/27/20
08:03
RMR

RMR Group

$28.05 /

-0.16 (-0.57%)

RMR Group announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RMR RMR Group
$28.05 /

-0.16 (-0.57%)

RMR RMR Group
$28.05 /

-0.16 (-0.57%)

07/14/20 Citi
RMR Group upgraded to Neutral from Sell at Citi
06/08/20 Citi
Citi downgrades Alternative Asset Managers to Market Weight, lowers four ratings
06/08/20 Citi
RMR Group downgraded to Sell from Neutral at Citi
04/17/20 Citi
Citi opens '30 Day Negative Catalyst Watch' on RMR Group
RMR RMR Group
$28.05 /

-0.16 (-0.57%)

Recommendations
Mustang Bio selloff not related to fundamentals, says B. Riley Securities » 08:02
10/27/20
10/27
08:02
10/27/20
08:02
MBIO

Mustang Bio

$2.66 /

-0.29 (-9.83%)

B. Riley Securities…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MBIO Mustang Bio
$2.66 /

-0.29 (-9.83%)

MBIO Mustang Bio
$2.66 /

-0.29 (-9.83%)

10/26/20 Oppenheimer
Oppenheimer sees case study supporting MB-105 development in prostate cancer
10/26/20 H.C. Wainwright
Mustang Bio's Phase 1 data in PSCA-mCRPC 'encouraging,' says H.C. Wainwright
10/02/20 B. Riley Securities
B. Riley starts Mustang Bio at Buy, sees 200% potential upside
10/02/20 B. Riley Securities
Mustang Bio initiated with a Buy at B. Riley Securities
MBIO Mustang Bio
$2.66 /

-0.29 (-9.83%)

  • 11
    Jun
MBIO Mustang Bio
$2.66 /

-0.29 (-9.83%)

Hot Stocks
JetBlue planning for gradual improvement in bookings through year-end » 08:02
10/27/20
10/27
08:02
10/27/20
08:02
JBLU

JetBlue

$12.57 /

-0.86 (-6.40%)

Expects continued…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JBLU JetBlue
$12.57 /

-0.86 (-6.40%)

JBLU JetBlue
$12.57 /

-0.86 (-6.40%)

10/07/20
Fly Intel: Top five analyst upgrades
10/07/20 JPMorgan
JPMorgan double upgrades JetBlue to Overweight on cost controls
10/07/20 JPMorgan
JetBlue upgraded to Overweight from Underweight at JPMorgan
09/08/20 Morgan Stanley
JetBlue initiated with an Overweight at Morgan Stanley
JBLU JetBlue
$12.57 /

-0.86 (-6.40%)

JBLU JetBlue
$12.57 /

-0.86 (-6.40%)

JBLU JetBlue
$12.57 /

-0.86 (-6.40%)

JBLU JetBlue
$12.57 /

-0.86 (-6.40%)

Earnings
Independent Bank reports Q3 EPS 89c, consensus 48c » 08:02
10/27/20
10/27
08:02
10/27/20
08:02
IBCP

Independent Bank

$14.88 /

-0.27 (-1.78%)

Total shareholders'…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IBCP Independent Bank
$14.88 /

-0.27 (-1.78%)

IBCP Independent Bank
$14.88 /

-0.27 (-1.78%)

10/02/20 Boenning & Scattergood
Independent Bank resumed with a Neutral at Boenning & Scattergood
04/01/20 Keefe Bruyette
Independent Bank upgraded to Outperform from Market Perform at Keefe Bruyette
01/17/20 DA Davidson
Independent Bank downgraded to Neutral from Buy at DA Davidson
IBCP Independent Bank
$14.88 /

-0.27 (-1.78%)

Downgrade
Live Nation downgraded to Hold from Buy at Jefferies » 08:01
10/27/20
10/27
08:01
10/27/20
08:01
LYV

Live Nation

$54.49 /

-2.69 (-4.70%)

Jefferies analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LYV Live Nation
$54.49 /

-2.69 (-4.70%)

LYV Live Nation
$54.49 /

-2.69 (-4.70%)

09/21/20 Morgan Stanley
Live Nation price target raised to $56 from $43 at Morgan Stanley
09/03/20 Citi
Live Nation price target raised to $58 from $47 at Citi
07/06/20 Citi
Live Nation price target raised to $47 from $35 at Citi
05/04/20 Cowen
Live Nation price target lowered to $55 from $65 at Cowen
LYV Live Nation
$54.49 /

-2.69 (-4.70%)

LYV Live Nation
$54.49 /

-2.69 (-4.70%)

LYV Live Nation
$54.49 /

-2.69 (-4.70%)

Hot Stocks
JetBlue sees Q4 capacity down ~45% y/y, revenue down 65% y/y » 08:01
10/27/20
10/27
08:01
10/27/20
08:01
JBLU

JetBlue

$12.57 /

-0.86 (-6.40%)

Revenue consensus is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JBLU JetBlue
$12.57 /

-0.86 (-6.40%)

JBLU JetBlue
$12.57 /

-0.86 (-6.40%)

10/07/20
Fly Intel: Top five analyst upgrades
10/07/20 JPMorgan
JPMorgan double upgrades JetBlue to Overweight on cost controls
10/07/20 JPMorgan
JetBlue upgraded to Overweight from Underweight at JPMorgan
09/08/20 Morgan Stanley
JetBlue initiated with an Overweight at Morgan Stanley
JBLU JetBlue
$12.57 /

-0.86 (-6.40%)

JBLU JetBlue
$12.57 /

-0.86 (-6.40%)

JBLU JetBlue
$12.57 /

-0.86 (-6.40%)

JBLU JetBlue
$12.57 /

-0.86 (-6.40%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.